323 related articles for article (PubMed ID: 15523011)
1. Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes.
Dickey ID; Rose PS; Fuchs B; Wold LE; Okuno SH; Sim FH; Scully SP
J Bone Joint Surg Am; 2004 Nov; 86(11):2412-8. PubMed ID: 15523011
[TBL] [Abstract][Full Text] [Related]
2. Chondrosarcoma of bone: an assessment of outcome.
Lee FY; Mankin HJ; Fondren G; Gebhardt MC; Springfield DS; Rosenberg AE; Jennings LC
J Bone Joint Surg Am; 1999 Mar; 81(3):326-38. PubMed ID: 10199270
[TBL] [Abstract][Full Text] [Related]
3. Dedifferentiated chondrosarcomas arising in preexisting osteochondromas.
Staals EL; Bacchini P; Mercuri M; Bertoni F
J Bone Joint Surg Am; 2007 May; 89(5):987-93. PubMed ID: 17473135
[TBL] [Abstract][Full Text] [Related]
4. [Dedifferentiated chondrosarcoma. A study of 13 clinical cases and review of the literature].
Anract P; Tomeno B; Forest M
Rev Chir Orthop Reparatrice Appar Mot; 1994; 80(8):669-80. PubMed ID: 7638395
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and Long-Term Outcome of Surgically Managed High-Grade Extremity Chondrosarcoma.
Gulbrandsen TR; Skalitzky MK; Russell MD; An Q; Hasan O; Miller BJ
Iowa Orthop J; 2023; 43(1):71-75. PubMed ID: 37383872
[TBL] [Abstract][Full Text] [Related]
6. Chondrosarcoma of the pelvis. A review of sixty-four cases.
Pring ME; Weber KL; Unni KK; Sim FH
J Bone Joint Surg Am; 2001 Nov; 83(11):1630-42. PubMed ID: 11701784
[TBL] [Abstract][Full Text] [Related]
7. Dedifferentiated chondrosarcoma--a fatal disease.
Bruns J; Fiedler W; Werner M; Delling G
J Cancer Res Clin Oncol; 2005 Jun; 131(6):333-9. PubMed ID: 15785935
[TBL] [Abstract][Full Text] [Related]
8. Does ifosfamide therapy improve survival of patients with dedifferentiated chondrosarcoma?
Kawaguchi S; Sun T; Lin PP; Deavers M; Harun N; Lewis VO
Clin Orthop Relat Res; 2014 Mar; 472(3):983-9. PubMed ID: 24197392
[TBL] [Abstract][Full Text] [Related]
9. What Factors Are Associated with Treatment Outcomes of Japanese Patients with Clear Cell Chondrosarcoma?
Nakayama R; Hayakawa K; Kobayashi E; Endo M; Asano N; Yonemoto T; Kawashima H; Hamada K; Watanabe I; Futani H; Goto T; Nishida Y; Ozaki T
Clin Orthop Relat Res; 2020 Nov; 478(11):2537-2547. PubMed ID: 32297725
[TBL] [Abstract][Full Text] [Related]
10. Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group.
Grimer RJ; Gosheger G; Taminiau A; Biau D; Matejovsky Z; Kollender Y; San-Julian M; Gherlinzoni F; Ferrari C
Eur J Cancer; 2007 Sep; 43(14):2060-5. PubMed ID: 17720491
[TBL] [Abstract][Full Text] [Related]
11. Pelvic chondrosarcomas: surgical treatment options.
Deloin X; Dumaine V; Biau D; Karoubi M; Babinet A; Tomeno B; Anract P
Orthop Traumatol Surg Res; 2009 Oct; 95(6):393-401. PubMed ID: 19801212
[TBL] [Abstract][Full Text] [Related]
12. Conventional Primary Central Chondrosarcoma of the Pelvis: Prognostic Factors and Outcome of Surgical Treatment in 162 Patients.
Bus MPA; Campanacci DA; Albergo JI; Leithner A; van de Sande MAJ; Gaston CL; Caff G; Mettelsiefen J; Capanna R; Tunn PU; Jeys LM; Dijkstra PDS
J Bone Joint Surg Am; 2018 Feb; 100(4):316-325. PubMed ID: 29462035
[TBL] [Abstract][Full Text] [Related]
13. Locally recurrent chondrosarcoma of the pelvis and limbs can only be controlled by wide local excision.
Laitinen MK; Parry MC; Le Nail LR; Wigley CH; Stevenson JD; Jeys LM
Bone Joint J; 2019 Mar; 101-B(3):266-271. PubMed ID: 30813783
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases.
Bergh P; Gunterberg B; Meis-Kindblom JM; Kindblom LG
Cancer; 2001 Apr; 91(7):1201-12. PubMed ID: 11283918
[TBL] [Abstract][Full Text] [Related]
15. Dedifferentiated parosteal osteosarcoma: the experience of the Rizzoli Institute.
Bertoni F; Bacchini P; Staals EL; Davidovitz P
Cancer; 2005 Jun; 103(11):2373-82. PubMed ID: 15852358
[TBL] [Abstract][Full Text] [Related]
16. Is Chemotherapy Associated with Improved Overall Survival in Patients with Dedifferentiated Chondrosarcoma? A SEER Database Analysis.
Cranmer LD; Chau B; Mantilla JG; Loggers ET; Pollack SM; Kim TS; Kim EY; Kane GM; Thompson MJ; Harwood JL; Wagner MJ
Clin Orthop Relat Res; 2022 Apr; 480(4):748-758. PubMed ID: 34648466
[TBL] [Abstract][Full Text] [Related]
17. Low-grade chondrosarcoma of long bones treated with intralesional curettage followed by application of phenol, ethanol, and bone-grafting.
Verdegaal SH; Brouwers HF; van Zwet EW; Hogendoorn PC; Taminiau AH
J Bone Joint Surg Am; 2012 Jul; 94(13):1201-7. PubMed ID: 22760388
[TBL] [Abstract][Full Text] [Related]
18. Survival and prognostic factors in chondrosarcoma: results in 115 patients with long-term follow-up.
Andreou D; Ruppin S; Fehlberg S; Pink D; Werner M; Tunn PU
Acta Orthop; 2011 Dec; 82(6):749-55. PubMed ID: 22066552
[TBL] [Abstract][Full Text] [Related]
19. Dedifferentiated chondrosarcoma revisited.
Mavrogenis AF; Ruggieri P; Mercuri M; Papagelopoulos PJ
J Surg Orthop Adv; 2011; 20(2):106-11. PubMed ID: 21838071
[TBL] [Abstract][Full Text] [Related]
20. Dedifferentiated Chondrosarcoma Demonstrating Osteosarcomatous Differentiation.
Dhinsa BS; DeLisa M; Pollock R; Flanagan AM; Whelan J; Gregory J
Oncol Res Treat; 2018; 41(7-8):456-460. PubMed ID: 29902785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
